Who we are
We are a biotechnology company whose main objective is to develop advanced therapies for the treatment of metabolic diseases. We use innovation to generate a positive impact on society. We want to develop drugs that can improve people’s lives, trying to make accessible new treatments that can reach patients.
Our target: Obesity
We want to combat the problem of obesity with an innovative approach, regulating the central mechanisms that control metabolism.
Our technology
We propose technologies capable of targeting our treatments in a very specific way, in order to access the brain areas that regulate metabolism.
The specificity we achieve guarantees the virtual elimination of unwanted side effects.